Inicio > BIGG > Resultado de la búsqueda

    Resultados: 3

    VA/DoD clinical practice guideline for the management of headache

    U.S. Government. USA Department of Defense. USA Department of Veterans Affairs.
    The VA and DoD Evidence-Based Practice Work Group (EBPWG) was established and first chartered in 2004, with a mission to advise the VA/DoD Health Executive Committee “on the use of clinical and epidemiological evidence to improve the health of the population . . .” across the Veterans Health Administ...
    Cefalea/tratamiento farmacológico, Cefalea/clasificación, Atención Dirigida al Paciente/normas, Estimulación Eléctrica Transcutánea del Nervio, Antagonistas de Receptores de Angiotensina/uso terapéutico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Antidepresivos/uso terapéutico, Anticonvulsivantes/uso terapéutico, Antagonistas Adrenérgicos beta/uso terapéutico, Cefalea/terapia
    Texto completo

    Headaches in over 12s: diagnosis and management

    England. National Institute for Health and Care Excellence.
    This guideline covers advice on the diagnosis and management of tension-type headache, migraine (including migraine with aura and menstrual-related migraine), cluster headache and medication overuse headache in young people (aged 12 years and older) and adults. It aims to improve the recognition and mana...
    Cefalea/diagnóstico, Cefalea/terapia, Cefalea/tratamiento farmacológico, Topiramato/uso terapéutico, Amitriptilina/uso terapéutico, Pizotilina/uso terapéutico
    Texto completo

    European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

    Sacco, S; Bendtsen, L; Ashina, M; Reuter, U; Terwindt, G; Mitsikostas, DD; Martelletti, P.
    J. Head. Pain; 20 (6), 2019
    BACKGROUND AND AIM: Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-relat...
    Trastornos Migrañosos, Trastornos Migrañosos/diagnóstico, Trastornos Migrañosos/tratamiento farmacológico, Trastornos Migrañosos/terapia, Trastornos Migrañosos/prevención & control, Receptores de Péptido Relacionado con el Gen de Calcitonina/uso terapéutico, Péptido Relacionado con Gen de Calcitonina/uso terapéutico, Cefalea, Cefalea/tratamiento farmacológico, Cefalea/diagnóstico, Cefalea/terapia, Cefalea/prevención & control
    Texto completo (enlace principal)     Texto completo (enlace alternativo)